Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Martin Jönsson — CEO

Roles

AlzeCure Pharma AB Stockholm
CEO
25.07.2025 – 02.07.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
02.07.2026AlzeCure Pharma AB Stockholm
New shares (subscription)
184,914SEK 1.31
SEK 242,237.34
↗
25.08.2025AlzeCure Pharma AB Stockholm
Bought — open marketAcquisition
8,067SEK 2.19
SEK 17,666.73
↗
29.07.2025AlzeCure Pharma AB Stockholm
New shares (subscription)
23,759SEK 2.20
SEK 52,269.80
↗
25.07.2025AlzeCure Pharma AB Stockholm
New shares (subscription)
178,549SEK 2.20
SEK 392,807.80
↗